Package Leaflet: Information for the User
ZARELIS Retard 300 mg prolonged-release tablets
venlafaxine
Contents of the pack and other information
Zarelis Retard contains the active substance venlafaxine.
Zarelis Retard is an antidepressant that belongs to a group of medicines called serotonin and norepinephrine reuptake inhibitors (SNRIs). This group of medicines is used to treat depression and other conditions such as anxiety disorders. It is not fully understood how antidepressants work, but they may help to increase the levels of serotonin and norepinephrine in the brain.
Zarelis Retard is a treatment for adults with depression. Treating depression and anxiety disorders properly is important to help you feel better. If left untreated, your condition may not improve or may become more difficult to treat.
Talk to your doctor or pharmacist before starting venlafaxine.
Venlafaxine may cause a feeling of restlessness or difficulty sitting or standing still during the first few weeks of treatment. You should consult your doctor if this happens to you.
Do not drink alcohol during treatment with Zarelis Retard, as it may cause extreme fatigue and unconsciousness. Taking it with certain medicines and/or alcohol may worsen symptoms of depression and other conditions, such as anxiety disorders.
If you are depressed and/or have an anxiety disorder, you may sometimes have thoughts of harming yourself or suicide. These suicidal thoughts may increase when you first start taking antidepressants, due to the fact that these medicines take time to work, usually around two weeks but sometimes longer. These thoughts may also occur when you reduce your dose or during the end of treatment with venlafaxine.
It is more likely to happen to you:
If you have thoughts of self-harm or suicide at any time, contact your doctor or go to a hospital directly.
You may find it helpful to tell a relative or close friend that you are depressed or have an anxiety disorder and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behavior.
Dry mouth
Dry mouth has been reported in 10% of patients treated with venlafaxine. This may increase the risk of dental decay (caries). Therefore, you should be careful with your dental hygiene.
Your blood sugar levels may be altered due to venlafaxine. Therefore, it may be necessary to adjust the dose of your diabetes medication.
Sexual problems
Some medicines in the same group as venlafaxine (called SNRIs) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms persist after stopping treatment.
Venlafaxine should not normally be used in the treatment of children and adolescents under 18 years of age. Additionally, you should know that in patients under 18 years of age, there is a greater risk of adverse effects such as suicidal attempts, suicidal thoughts, and hostility (mainly aggression, confrontational behavior, and irritation) when taking this class of medicines. Nevertheless, the doctor who prescribes it to you may prescribe this medicine to patients under 18 years of age when they decide it is most convenient for the patient. If the doctor who prescribes it to you has prescribed this medicine to a patient under 18 years of age and you wish to discuss this decision, please go back to your doctor. You should inform your doctor if any of the above symptoms develop or worsen when these patients under 18 years of age are taking venlafaxine. Additionally, the long-term effects on safety, growth, maturity, and cognitive and behavioral development have not yet been demonstrated.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Your doctor will decide whether you can take Zarelis Retard with other medicines.
Do not start or stop taking any medicines, including those that can be bought without a prescription, natural remedies, or herbal products, before checking with your doctor or pharmacist.
Serotonin syndrome, a potentially life-threatening condition, or Neuroleptic Malignant Syndrome (NMS) (see section “Possible side effects”), may occur with venlafaxine treatment, particularly when taken with other medicines.
Examples of these medicines include:
The signs and symptoms of Serotonin syndrome may include a combination of the following: restlessness, hallucinations, loss of coordination, rapid heartbeat, increased body temperature, rapid changes in blood pressure, overactive reflexes, diarrhea, coma, nausea, vomiting.
Serotonin syndrome, in its most severe form, can resemble Neuroleptic Malignant Syndrome (NMS). The symptoms and signs of NMS can include a combination of fever, rapid heartbeat, sweating, severe muscle stiffness, confusion, increased levels of muscle enzymes (determined in blood).
Tell your doctor immediately or go to the nearest hospital if you think you are suffering from Serotonin syndrome.
You should tell your doctor if you are taking medicines that affect your heart rhythm. Examples of these medicines include:
The following medicines may also interact with venlafaxine and should be used with caution. It is especially important to mention to your doctor or pharmacist if you are taking medicines containing:
Venlafaxine should be taken with food (see section 3 “How to take Zarelis Retard”).
Do not drink alcohol during treatment with Zarelis Retard. Taking it with alcohol may cause extreme fatigue and unconsciousness, and worsen symptoms of depression and other conditions, such as anxiety disorders.
If you are pregnant or breastfeeding, if you think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. You should only take venlafaxine after discussing with your doctor the possible benefits and risks to the unborn child.
Make sure your midwife and/or doctor knows that you are using venlafaxine. When similar medicines (called selective serotonin reuptake inhibitors: SSRIs) are taken during pregnancy, there may be an increased risk that the baby will suffer from a serious disease called persistent pulmonary hypertension of the newborn (PPHN), causing the child to breathe faster and appear blue. These symptoms usually start during the first 24 hours after birth. If this happens to you, you should contact a doctor and/or midwife immediately.
If you take venlafaxine in the final stage of pregnancy, there may be an increased risk of heavy vaginal bleeding shortly after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking Zarelis Retard so they can advise you.
If you are taking this medicine during pregnancy, other symptoms that your baby may have when born are feeding problems and breathing problems. If your baby has these symptoms when born and you are concerned, contact your doctor and/or midwife who can advise you.
Venlafaxine passes into breast milk. There is a risk of an effect on the baby, so you should discuss this with your doctor, and they will decide whether you should stop breastfeeding or stop taking this medicine.
Driving and using machines
Do not drive or operate tools or machines until you know how venlafaxine affects you.
Zarelis Retard contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The usual recommended initial dose for the treatment of depression, generalized anxiety disorder, and social anxiety disorder is 75 mg per day. Your doctor may gradually increase the dose, and if necessary, raise it to a maximum of 375 mg per day for depression.
Take venlafaxine approximately at the same time each day, either in the morning or evening. The tablets should be swallowed whole with liquids and should not be opened, crushed, chewed, or dissolved.
Zarelis Retard should be taken with food.
If you have liver or kidney problems, talk to your doctor, as you may need a different dose of this medicine.
Do not stop taking venlafaxine without consulting your doctor (see section “If you stop taking Zarelis Retard”).
Contact your doctor or pharmacist immediately if you take more medicine than prescribed by your doctor. You can also contact the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
Overdose can put your life in danger, especially when taken with certain medicines and/or alcohol (see “Taking Zarelis Retard with other medicines”).
The symptoms of a possible overdose may include palpitations, changes in the level of consciousness (ranging from drowsiness to coma), blurred vision, seizures or fits, and vomiting.
If you miss a dose, take it as soon as you remember. However, if it is already time for your next dose, skip the missed dose and take only a single dose as usual. Do not take a double dose to make up for a forgotten dose. Do not take more than the daily dose of venlafaxine that has been prescribed to you in one day.
Do not stop taking your treatment or reduce the dose without your doctor's advice, even if you feel better. If your doctor thinks you no longer need venlafaxine, they may ask you to reduce the dose gradually before stopping treatment completely. It is known that side effects occur when people stop using this medicine, especially when it is stopped suddenly or if the dose is reduced too quickly. Some patients may experience symptoms such as suicidal thoughts, aggression, fatigue, dizziness, instability, headache, insomnia, nightmares, dry mouth, loss of appetite, nausea, diarrhea, nervousness, agitation, confusion, ringing in the ears, tingling, or, in rare cases, sensations of electric shock, weakness, sweating, seizures, or flu-like symptoms, vision problems, and increased blood pressure (which can cause headache, dizziness, ringing in the ears, sweating, etc.).
Your doctor will advise you on how to gradually stop taking venlafaxine. This may take several weeks or months. In some patients, the discontinuation may need to be very gradual over periods of several months or more. If you experience any of these or other symptoms that bother you, consult your doctor for further advice.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If any of the following effects occur, do not take more venlafaxine. Inform your doctor immediately, or go to the emergency department of the nearest hospital:
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Serotonin Syndrome, in its most severe form, can resemble Neuroleptic Malignant Syndrome (NMS). The symptoms and signs of NMS may include a combination of fever, rapid heartbeat, sweating, severe muscle stiffness, confusion, increased levels of muscle enzymes (determined in blood).
Frequency unknown (cannot be estimated from available data)
Other side effects that you should report to your doctor include (the frequency of these adverse effects is included in the list below “other side effects that may occur”):
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 patients)
Very rare (may affect up to 1 in 10,000 people)
Frequency unknown (frequency cannot be estimated from available data)
Venlafaxine sometimes produces unwanted effects that you may not be aware of, such as increased blood pressure or an abnormal heartbeat; slight changes in blood levels of liver enzymes, sodium, or cholesterol. Less frequently, Zarelis Retard may reduce the function of blood platelets, leading to an increased risk of bruising or bleeding. Therefore, your doctor may want to perform occasional blood tests, especially if you have been taking Zarelis Retard for a long time.
If you experience any of the side effects, inform your doctor or pharmacist. This includes any side effect not listed in this leaflet.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the packaging, after EXP. The expiration date is the last day of the month indicated.
This medicine does not require any special storage temperature. Store in the original packaging to protect it from moisture.
Do not throw any medicine down the drain or into the trash. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
The active ingredient is venlafaxine.
Each tablet contains 300 mg of venlafaxine (as hydrochloride).
The other ingredients are: mannitol (E421), povidone, macrogol, colloidal anhydrous silica, microcrystalline cellulose (E 460(i)), magnesium stearate (E 470b), cellulose acetate, hypromellose, lactose monohydrate, titanium dioxide (E171), and triacetin.
Prolonged-release tablets of 300 mg, round, biconvex, white or almost white.
Zarelis Retard 300 mg is available in blisters of 10, 14, 20, 28, 30, 42, 50, 56, 60, 98, 100, and 500 tablets. Not all pack sizes may be marketed.
Marketing authorization holder:
ITALFARMACO, S.A.
San Rafael, 3 – 28108 Alcobendas (Madrid), SPAIN
Manufacturer:
Laboratorios LICONSA, S.A.
Avda. Miralcampo, Nº 7, Polígono Industrial Miralcampo
19200 Azuqueca de Henares (Guadalajara), SPAIN
or
Sandoz A/S
Edvard Thomsens Vej 14, 2300 København S,
Denmark
or
Genericon Pharma
Gesellschaft m.b.H.,
Hafnerstrasse 21, 8054 Graz,
Austria
This medicine is authorized in the Member States of the European Economic Area under the following names:
Member State | Medicine name |
Sweden | Venlafaxin Liconsa 75mg prolonged-release tablets |
Austria | Venlafaxin +pharma 75mg retard tablets |
Spain | Zarelis Retard 75mg prolonged-release tablets |
Hungary | Faxiprol 75mg retard tablet |
Germany | Venlafaxin AAA-Pharma 75mg retard tablets |
Finland | Venlafaxin Sandoz 75 mg prolonged-release tablets |
Date of last revision of this leaflet:February 2025
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
Other sources of information
Detailed information on this medicine is available on the website of the European Medicines Agency: https://www.ema.europa.eu
The average price of ZARELIS RETARD 300 mg PROLONGED-RELEASE TABLETS in October, 2025 is around 38.31 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.